RE:RE:RE:COVID and the risk of lung diseasesDr kolb sees an interest in lung disease treatment which no doubt his continuing studies will clarify more if it's of interest
The point is that Covid 19 as a serious health threat hs greatly reduced - hence lung Infractions sourced by the virus will be much limited in numbers compared to what was seen at pandemic levels
this means probably funds providers will not be attracted to a projet in this area The winners in Covid solutions are now moved away from it - at pandemic levels any solution possibility around Covid 19 had great interest - ( no doubt was why czo spoke to it for a period before deciding to stop communicating last year )